Asymmetric synthesis of the nonproteinogenic silicon-containing α-amino acids (R)- And (5)-α-[(trimethylsilyl)methyl] alanine

Organometallics

Volumn 28, Issue 20, 2009, Pages 6059-6066

  Falgner, Steffen ^a   Burschka, Christian ^a   Wagner, Stephan ^a   Böhm, Andreas ^b   Daiss, Jürgen O ^b   Tacke, Reinhold ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b WACKER CHEMIE AG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ABSOLUTE CONFIGURATION; ASYMMETRIC SYNTHESIS; CRYSTAL STRUCTURE ANALYSIS; DIETHYL MALONATES; ENANTIOMERIC PURITY; ENANTIOSELECTIVE; MALONATES; MULTI-STEP; PORCINE LIVER ESTERASE; PROPANOIC ACID; RHODIUM COMPLEXES; TRIMETHYLSILYL;

AMINATION; AMINES; AMINO ACIDS; ESTERS; ORGANIC ACIDS; RHODIUM; RHODIUM COMPOUNDS; SYNTHESIS (CHEMICAL);

CRYSTAL STRUCTURE;

EID: 70350317339     PISSN: 02767333     EISSN: None     Source Type: Journal    
DOI: 10.1021/om900583d     Document Type: Article

References (52)

1. Wirth, T. Angew. Chem. 1997,109, 235-237.
2. Angew. Chem., Int. Ed. Engl. 1997,36, 225-227.
3. Cativiela, C; Díaz-de-Villegas, M. D. Tetrahedron: Asymmetry 1998,9,3517-3599.
4. Vogt, H.; Bräse, S. Org. Biomol. Chem. 2007, 5,406-430.
5. Tanaka, M. Chem. Pharm. Bull. 2007, 55, 349-358.
6. (a) Tacke, R.; Merget, M.; Bertermann, R.; Bernd, M.; Beckers, T.; Reissmann, T. Organometallics 2000,19, 3486-3497.
7. (b) Handmann, V. I.; Merget, M.; Tacke, R. Z. Naturforsch. 2000,55b, 133-138.
8. (c) Merget, M.; Günther, K.; Bernd, M.; Günther, E.; Tacke, R. J. Organomet. Chem. 2001,628,183-194.
9. (d) Tacke, R.; Handmann, V. I. Organometallics 2002, 21, 2619-2626.
10. (e) Tacke, R.; Schmid, T.; Merget, M. Organometallics 2005,24,1780-1783.
11. (f) Falgner, S.; Schmidt, D.; Bertermann, R.; Burschka, C.; Tacke, R. Organometallics 2009, 28, 2927-2930.
12. (a) Birkofer, L.; Ritter, A. Angew. Chem. 1956, 68, 461-462.
13. (b) Porter, T. H.; Shive, W. J. Med. Chem. 1968, 11, 402-403.
14. (c) Fitzi, R.; Seebach, D. Tetrahedron 1988,44,5277-5292.
15. (d) Weidmann, B. Chimia 1992, 46,312-313.
16. (e) Walkup, R. D.; Cole, D. C.; Whittlesey, B. R. J. Org. Chem. 1.995, 60, 2630-2634.
17. (f) Yamanaka, H.; Fukui, T.; Kawamoto, T.; Tanaka, A. Appl. Microbiol. Biotedmol. 1996,45,51-55.
18. (g) Sibi, M. P.; Harris, B. J.; Shay, J. J.; Hajra, S. Tetrahedron 1998,54,7221-7228.
19. (h) Ishikawa, H.; Yamanaka, H,; Kawamoto, T.; Tanaka, A. Appl. Microbiol. Biotechnol. 1999,53,19-22.
20. Pietzsch, M.; Waniek, T.; Smith, R. J.; Svetoslav, B.; Bienz, S.; Syldatk, C. Monatsh. Chem. 2000,131, 645-653.
21. (j) Vivet, B.; Cavelier, E; Martinez, J. Eur. J. Org. Chem. 2000, 807-811.
22. (k) Bolm, G; Kasyan, A,; Drauz, K.; Günther, K; Raabe, G. Angew. Chem. 2000,112,2374-2376;
23. Angew. Chem, Int. Ed. 2000,39,2288-2290.
24. (l) Cavelier, F.; Vivet, B.; Martinez, J.; Aubry, A.; Didierjean, C.; Vicherat, A.; Marraud, M. J. Am. Chem. Soc. 2002,124,2917-2923.
25. (m) Chen, J.-X.; Tunge, J. A.; Norton, J. R. J. Org. Chem. 2002,67,4366-4369.
26. (n) Liu, G.; Sieburth, S. McN. Org. Lett. 2003, 5, 4611-4619.
27. (o) Kenworthy, M. N.; Kilburn, J. P.; Taylor, R. J. K. Org. Lett. 2004, 6, 19-22.
28. (p) Smith, R. J.; Bienz, S. Helv. Chim. Acta. 2004,87,1681-1696.
29. (q) Cavelier, F.; Marchand, D.; Martinez, J.; Sagan, S. J. Peptide Res. 2004,63,290-296.
30. (r) Liu, G.; Sieburth, S. McN. Org. Lett. 2005, 7,665-668.
31. (s) Link, J. O.; Graupe, M. (Axys Pharmaceuticals Inc.) PCT Int. Pat. Appl. WO 2005/074904 A2, August 18,2005.
32. (t) Regulato, G.; Mordini, A.; Mettre, P.; Tenti, A.; Valacchi, M.; Cariou, K. Tetrahedron: Asymmetry 2006, 17, 922-926.
33. (u) Cavelier, F.; Marchand, D.; Martinez, J. Chem. Biodiversity 2008,5,1279-1287.
34. (v) Marchand, D.; Martinez, J.; Cavelier, E Eur. J. Org. Chem. 2008,3107-3112.
35. Tacke, R..; Wagner, S. A. The Chemistry of Organic Silicon Compounds: Rappoport, Z.; Apeloig, Y, Eds.; John Wiley & Sons: Chichester, U.K., 1998; Vol.2, Part 3, pp 2363-2400.
36. 29Si).
37. 1H NMR spectroscopy), the intermediate ethyl rac-3-azido-2-methyl-3oxo-2- [(trimethylsilyl)methyl]propanoate was not isolated.
38. De Jeso, B.; Belair, N.; Deleuze, H.; Rascle, M.-C.; Maillard, B. Tetrahedron Lett. 1990, 31, 653-654.
39. Repeated recrystallization of (S)-13 from n-hexane at -20 °C yielded a product with an enantiomeric purity of > 99% ee; however, the yield was very poor. The melting point and the specific optical rotation given in the Experimental Section refer to the recrystallized product (>99%ee).
40. Krämer, R.; Polborn, K.; Wanjek, H.; Zahn, I.; Beck, W. Chem. Ber. 1990, 123, 767-778.
41. The hydrogen-bonding systems were analyzed by using the program system PLA TON: Spek, A. L. PLATON; University of Utrecht: Utrecht, The Netherlands, 2008.
42. (a) Flack, H. D.; Bernardinelli, G. Acta Crystallogr., Sect. A 1999, 55, 908-915.
43. (b) Flack, H. D.; Bernardinelli, G. J. Appl. Crystallogr. 2000, 55, 1143-1148.
44. (a) Campbell, A..; Kenyon, J. J. Chem. Soc. 1946, 25-27.
45. (b) Jewett, J. C.; Rawal, V. H. Angew. Chem. 2007,119, 6622-6624.
46. Angew. Chem., Int. Ed. 2007,46, 6502-6504.
47. (a) WIN-DAISY 4.05; Bruker-Franzen GmbH: Bremen, Germany, 1998.
48. (b) Weber, U.; Germanus, A.; Thiele, H. Fresenius J. Anal. Chem. 1997, 359,46-49.
49. The molar ratio takes into account the amount of rac-1 -HCl, (R)-1 HCl, or (S)-1• HCl obtained in the former step.
50. ( 18) The enantiomeric purity was not determined for this compound, but is supposed to be 85% ee.
51. To measure the NMR. spectra of (5)-12, the solvent of the reaction solution (CH2CI2) was removed in vacuo and the residue was dissolved in C&Df,.
52. Sheldrick, G. M. Acta Crystallogr., Sect. A 2008, 64,112-122.